We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTCT icon
1376
NETSCOUT
NTCT
$3.07B
$15K ﹤0.01%
433
+112
+35% +$4.05K
PLG
1377
Platinum Group Metals
PLG
$176M
$15K ﹤0.01%
1,451
+1,221
+531% +$14.2K
PRGO icon
1378
Perrigo
PRGO
$1.49B
$15K ﹤0.01%
205
-462
-69% -$33.1K
RELX icon
1379
RELX
RELX
$64.2B
$15K ﹤0.01%
+671
New +$14.1K
SANW
1380
DELISTED
S&W Seed Co
SANW
$15K ﹤0.01%
184
+19
+12% +$1.6K
TMF icon
1381
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.18B
$15K ﹤0.01%
+70
New +$14.2K
USAP
1382
DELISTED
Universal Stainless & Alloy
USAP
$15K ﹤0.01%
746
+610
+449% +$11K
ICPT
1383
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$15K ﹤0.01%
128
+86
+205% +$9.96K
DCP
1384
DELISTED
DCP Midstream, LP
DCP
$15K ﹤0.01%
434
-327
-43% -$11.7K
NVCN
1385
DELISTED
Neovasc Inc.
NVCN
0
MYOV
1386
DELISTED
Myovant Sciences Ltd.
MYOV
$15K ﹤0.01%
1,319
+999
+312% +$12.4K
SRNE
1387
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$15K ﹤0.01%
7,596
+6,885
+968% +$13.4K
AHPI
1388
DELISTED
Allied Healthcare Products
AHPI
$15K ﹤0.01%
+5,270
New +$10.8K
JRJC
1389
DELISTED
China Finance Online Co., Ltd.
JRJC
$15K ﹤0.01%
859
+777
+948% +$18K
EXFO
1390
DELISTED
EXFO INC.
EXFO
$15K ﹤0.01%
2,500
+2,000
+400% +$9.74K
MR
1391
DELISTED
Montage Resources Corporation Common Stock
MR
$15K ﹤0.01%
+353
New +$12.3K
AFH
1392
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$15K ﹤0.01%
+1,047
New +$14.8K
WBC
1393
DELISTED
WABCO HOLDINGS INC.
WBC
$15K ﹤0.01%
120
-380
-76% -$45.5K
VIAB
1394
DELISTED
Viacom Inc. Class B
VIAB
$15K ﹤0.01%
449
-1,297
-74% -$49.4K
ANCX
1395
DELISTED
Access National Corp
ANCX
$15K ﹤0.01%
556
+256
+85% +$7.21K
PHIIK
1396
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$15K ﹤0.01%
1,499
+416
+38% +$4.38K
MRVC
1397
DELISTED
MRV Communications Inc
MRVC
$15K ﹤0.01%
1,572
+1,509
+2,395% +$14.3K
WOOF
1398
DELISTED
VCA Inc.
WOOF
$15K ﹤0.01%
163
-41
-20% -$3.77K
OIL
1399
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$15K ﹤0.01%
3,100
+1,800
+138% +$9.31K
ADTN icon
1400
Adtran
ADTN
$710M
$14K ﹤0.01%
+660
New +$13.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.